U.S. market Closed. Opens in 11 hours 9 minutes

ALNY | Alnylam Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-31
Revenue1.83B1.04B844.29M492.85M219.75M74.91M89.91M47.16M41.10M50.56M47.17M66.72M82.76M100.04M100.53M96.16M50.90M26.93M5.72M4.28M176.00KN/A
Cost of Revenue310.41M168.82M140.14M78.05M25.06M1.80MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit1.52B868.60M704.14M414.80M194.69M73.11MN/AN/AN/AN/AN/AN/A82.76M100.04M100.53M96.16MN/AN/AN/AN/AN/AN/A
Operating Expenses1.80B1.65B1.41B1.24B1.13B887.78M590.00M471.75M337.11M234.78M140.11M130.29M137.57M144.11M148.64M124.00M144.07M66.43M49.19M36.54M20.62MN/A
Selling, General & Admin795.65M770.66M620.64M588.42M479.00M382.36M199.37M89.35M60.61M44.53M27.15M43.72M38.28M37.73M39.91M27.11M23.39M16.63M13.87M11.94M7.53M880.00K
Research & Development1.00B883.01M792.16M654.82M655.11M505.42M390.63M382.39M276.50M190.25M112.96M86.57M99.30M106.38M108.73M96.88M120.69M49.80M35.32M24.60M13.10M3.34M
Other Operating Expenses-17.74M-109.37M-2.05M45.52M20.73M4.17MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-4.22M
Operating Income-282.18M-785.07M-708.65M-828.44M-939.43M-814.67M-500.09M-424.59M-296.01M-184.21M-92.94M-63.57M-54.82M-44.07M-48.11M-27.84M-93.18M-39.50M-43.47M-32.26M-20.45M-4.22M
Other Expenses / Income-151.34M-341.92M-143.49M-27.16M54.18M24.74M9.21M14.48M5.93M-216.39M1.02M-53.02M-2.83M1.07M1.10M2.31M12.96M-255.00K-22.00K-233.00K-4.64MN/A
Before Tax Income-433.52M-1.13B-852.14M-855.60M-885.25M-760.67M-490.87M-410.11M-290.07M-400.60M-91.92M-116.59M-57.65M-43.00M-47.01M-25.53M-80.22MN/AN/AN/AN/AN/A
Income Tax Expenses6.72M4.16M680.00K2.68M863.00K823.00KN/AN/AN/A-40.21M-2.69M-10.57MN/A514.00K582.00K719.00K5.25MN/AN/AN/AN/AN/A
Net Income-440.24M-1.13B-852.82M-858.28M-886.12M-761.50M-490.87M-410.11M-290.07M-360.39M-89.22M-106.01M-57.65M-43.52M-47.59M-26.25M-85.47M-34.61M-42.91M-32.65M-25.03M-4.14M
Interest Expenses121.22M155.97M143.02M84.50MN/A29.26M12.24MN/AN/AN/AN/AN/AN/AN/AN/A872.00KN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding124.91M121.69M118.45M114.99M109.26M100.59M90.55M85.60M83.99M74.28M61.55M50.29M42.41M42.04M41.63M41.08M38.66M31.89M21.95M11.89M942.66K331.34K
Diluted Shares Outstanding124.91M121.69M118.45M114.99M109.26M100.59M90.55M85.60M83.99M74.28M61.55M50.29M42.41M42.04M41.63M41.08M38.66M31.89M21.95M11.89M942.66K331.34K
EBITDA-228.12M-894.44M-709.12M-771.10M-939.43M-835.24M-465.27M-394.98M-271.02M-388.68M-81.69M-107.55M-52.52M-38.06M-41.02M-18.93M-76.14M-30.79M-39.80M-30.21M-24.20M-4.19M
EBITDA Margin-12.48%-86.22%-83.99%-156.46%-427.50%-1,115.02%-517.47%-837.55%-659.47%-768.73%-173.20%-161.19%-63.47%-38.04%-40.80%-19.69%-149.59%-114.34%-696.20%-706.17%-13,747.16%0.00%
EBIT-312.30M-971.02M-709.12M-771.10M-885.25M-731.41M-478.64M-410.11M-290.07M-400.60M-91.92M-116.59M-57.65M-43.00M-47.01M-24.66M-80.22M-34.61M-42.91M-32.65M-25.03M-4.14M
EBIT Margin-17.08%-93.60%-83.99%-156.46%-402.85%-976.41%-532.34%-869.63%-705.83%-792.32%-194.88%-174.73%-69.66%-42.98%-46.76%-25.64%-157.61%-128.51%-750.77%-763.30%-14,223.30%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙